(AZE) Azelis - Ratings and Ratios

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974400328

AZE EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of AZE over the last 5 years for every Quarter.

AZE Revenue

This chart shows the Revenue of AZE over the last 5 years for every Quarter.

AZE: Specialty Chemicals, Food Ingredients

Azelis Group NV is a global distributor and seller of specialty chemicals and food ingredients, catering to diverse industries such as life sciences, industrial chemicals, and advanced materials. Their product portfolio supports various applications, including personal care, pharmaceuticals, food and nutrition, and agricultural solutions. With a presence in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific, Azelis leverages its extensive geographical footprint to deliver tailored solutions to its customers.

The companys business model is built around providing specialized products and services to a broad range of industries, allowing it to capitalize on growth opportunities across multiple sectors. Azelis expertise in navigating complex supply chains and its ability to deliver high-quality products position it as a reliable partner for its customers. With a history dating back to 1996, Azelis has established itself as a significant player in the specialty chemicals distribution market.

From a technical analysis perspective, Azelis stock price has been trending below its medium to long-term moving averages, with the SMA20 and SMA50 indicating a short-term consolidation phase, while the SMA200 suggests a longer-term downtrend. The ATR indicates a relatively moderate volatility. Given the current price at 14.01 EUR, the stock is closer to its 52-week low (13.16 EUR) than its high (20.94 EUR), suggesting a potential for recovery or stabilization.

Combining the technical insights with fundamental data, Azelis market capitalization stands at 3513.43M EUR, with a P/E ratio of 18.85 and a forward P/E of 16.95, indicating a moderate valuation relative to its earnings. The Return on Equity (RoE) of 9.35% suggests a decent profitability. Considering these metrics, a forecast for Azelis could involve a potential price recovery towards the 16-17 EUR range in the short to medium term, driven by a combination of technical rebound and fundamental stability, assuming the specialty chemicals market continues to grow and the company maintains its market share.

Based on the available data, a potential trading strategy could involve monitoring the stocks price action around the 13.16 EUR level for signs of support, and considering positions as it approaches the 14.58 EUR (SMA20) and 14.75 EUR (SMA50) levels, with a longer-term target potentially around 17-18 EUR, aligned with the SMA200 and factoring in the fundamental outlook.

Additional Sources for AZE Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

AZE Stock Overview

Market Cap in USD 3,760m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

AZE Stock Ratings

Growth Rating -62.9
Fundamental 68.4
Dividend Rating 50.2
Rel. Strength -24.3
Analysts -
Fair Price Momentum 11.41 EUR
Fair Price DCF 49.73 EUR

AZE Dividends

Dividend Yield 12m 1.38%
Yield on Cost 5y 0.79%
Annual Growth 5y 54.20%
Payout Consistency 93.8%
Payout Ratio 29.7%

AZE Growth Ratios

Growth Correlation 3m -68.1%
Growth Correlation 12m -38.1%
Growth Correlation 5y -75.7%
CAGR 5y -17.12%
CAGR/Max DD 5y -0.32
Sharpe Ratio 12m -0.56
Alpha -28.75
Beta 0.614
Volatility 34.34%
Current Volume 272.3k
Average Volume 20d 255.2k
What is the price of AZE shares?
As of June 26, 2025, the stock is trading at EUR 13.59 with a total of 272,287 shares traded.
Over the past week, the price has changed by +3.90%, over one month by -9.34%, over three months by -24.04% and over the past year by -24.37%.
Is Azelis a good stock to buy?
Yes, based on ValueRay´s Fundamental Analyses, Azelis (BR:AZE) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 68.43 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AZE is around 11.41 EUR . This means that AZE is currently overvalued and has a potential downside of -16.04%.
Is AZE a buy, sell or hold?
Azelis has no consensus analysts rating.
What are the forecasts for AZE share price target?
According to our own proprietary Forecast Model, AZE Azelis will be worth about 12.6 in June 2026. The stock is currently trading at 13.59. This means that the stock has a potential downside of -7.28%.
Issuer Target Up/Down from current
Wallstreet Target Price 21.4 57.5%
Analysts Target Price - -
ValueRay Target Price 12.6 -7.3%